Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety, tolerability, and efficacy of nefopam cream in burn patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nefopam Cream (nefopam)

Snippet

Sponsor: University of Alberta | Conditions: Burn; Multiple Body Regions, Max. Second Degree, Third-Degree Burn | Phase 2 | Status: COMPLETED